Ferrous Fumarate + Folic Acid + Zinc Sulphate MonohydrateThird Party Manufacturing in India

This triple combination formulation works through three complementary mechanisms to address anemia and nutritional deficiencies. Ferrous fumarate provides bioavailable elemental iron, which is absorbed in the duodenum and proximal jejunum via the divalent metal transporter 1 (DMT1). Once absorbed, iron is transported by transferrin to the bone marrow where it is incorporated into hemoglobin for red blood cell production. Iron is also essential for myoglobin, cytochrome enzymes, and various metabolic processes.

Folic acid, the synthetic form of folate, is converted in the body to its active metabolite, 5-methyltetrahydrofolate. This reduced folate is essential for DNA synthesis, repair, and methylation. In erythropoiesis, folate is required for the synthesis of purines and pyrimidines, making it critical for the rapid cell division that occurs in the bone marrow during red blood cell formation. Folic acid supplementation prevents megaloblastic changes in the bone marrow.

Zinc sulphate monohydrate provides zinc, a trace mineral that acts as a cofactor for over 300 enzymes involved in protein synthesis, cellular metabolism, and immune function. Zinc plays a crucial role in hemoglobin synthesis, cell growth, and maintaining the integrity of the immune system. The combination of these three nutrients provides comprehensive support for erythropoiesis and overall nutritional health.

Therapeutic Uses

This combination is prescribed for:

• Iron Deficiency Anemia: Ferrous fumarate provides elemental iron to replenish depleted iron stores and normalize hemoglobin levels in patients with iron deficiency anemia.
• Megaloblastic Anemia due to Folate Deficiency: Folic acid corrects folate deficiency and prevents neural tube defects in pregnant women.
• Anemia in Pregnancy: This combination is widely used during pregnancy to meet the increased demands for iron, folate, and zinc for both maternal health and fetal development.
• Nutritional Deficiencies: In pediatric and adolescent populations with poor dietary intake, this combination corrects multiple micronutrient deficiencies simultaneously.
• Post-Surgical and Chronic Blood Loss Anemia: Patients recovering from surgery or with chronic blood loss benefit from the iron and folate replenishment.
• Zinc Deficiency States: Zinc supplementation supports immune function, wound healing, and growth in deficient individuals.

Why Manufacturers Choose Ferrous Fumarate + Folic Acid + Zinc Sulphate

This triple combination is one of the highest-volume formulations in the Indian pharmaceutical market, driven by government health programs, maternal health initiatives, and widespread prevalence of anemia across all age groups. India's National Nutritional Anemia Control Program and the Anaemia Mukt Bharat campaign have created massive institutional demand for iron-folate-zinc combinations. Third party manufacturers in India produce millions of tablets monthly for PCD franchise networks, institutional tenders, and export markets. The formulation uses well-characterized, low-cost raw materials with established supply chains. Its inclusion in the WHO Essential Medicines List and various national formularies ensures consistent long-term demand, making it an ideal volume driver for contract manufacturing operations.